Arkolith/Insider Trading/DNTH/Form 4

Randhawa Simrat

EVP, Head of R&DDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.8M
Net Open-Market Flow
-$2.8M
Transactions
9
5 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)13K$22.07$276K34K
Mar 12, 2026Option exercise(M)8K$21.77$181K21K
Mar 12, 2026Option exercise(M)5K$17.88$89K13K
Mar 12, 2026Option exercise(M)8K$8.44$68K8K
Mar 12, 2026Sell(S)34K$81.48$2.8M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)8K—$054K
Mar 12, 2026Option exercise(M)13K—$0106K
Mar 12, 2026Option exercise(M)8K—$04K
Mar 12, 2026Option exercise(M)5K—$071K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001992260-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML